Effect of Diacylglycerol Oil on Risk Factors of Type 2 Diabetes and Complicating Disease, and Mechanism
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Diacylglycerol oil has been shown to lower postprandial and fasting serum triacylglycerol levels and reduce body fat. The investigators hypothesize that replacing dietary fat with diacylglycerol oil reduces excess body fat in type 2 diabetic patients and that diacylglycerol oil has a beneficial effect on cardiovascular risk factors in Chinese type 2 diabetic patients.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
40 Years to 70 Years (Adult, Senior)
Sexes Eligible for Study:
Type 2 diabetic patients, blood sugar levels were stabilized between 7.0－10.0 mmol/L
Male, aged 40 - 70 years old, Female, aged post-menopausal - 70 years old.
Overweight/obese patients (BMI 25 - 40 kg/m2)
Currently under diet therapy for diabetes mellitus
Understands the procedures and willing to participate in the study
Patients who unwilling to give informed consent
Type 1 diabetic patients
Familial hyperlipemia patients or blood triacylglycerol concentration > 400 mg/dl
Patients with a history of cardiovascular disease and/or arteriosclerotic disease
Patients with a history of cerebrovascular disease
Patients with serious hepatic disease and/or renal disease
Patients with malignancy
Participation in another clinical study within 30 days prior to screening period.
Has a condition the doctor in charge believes would interfere with evaluation of the subject, or may put subject at undue risk